119 related articles for article (PubMed ID: 3499544)
1. A hairy cell leukemia associated antigen (HC2) has a distinct role in normal B cell differentiation.
Posnett DN; Folkl RJ; Wang CY
Leukemia; 1987 Apr; 1(4):383-6. PubMed ID: 3499544
[TBL] [Abstract][Full Text] [Related]
2. An antigen characteristic of hairy cell leukemia cells is expressed on certain activated B cells.
Posnett DN; Wang CY; Chiorazzi N; Crow MK; Kunkel HG
J Immunol; 1984 Sep; 133(3):1635-40. PubMed ID: 6431005
[TBL] [Abstract][Full Text] [Related]
3. Expression of the B8.7 antigen on hairy cells and relation with the LMW-BCGF response.
Génot E; Leprince C; Richard Y; Petit-Koskas E; Falcoff E; Galanaud P; Sigaux F; Kolb JP
Leukemia; 1989 May; 3(5):367-72. PubMed ID: 2785622
[TBL] [Abstract][Full Text] [Related]
4. Hairy cell leukemia-associated antigen (HC2) is an activation antigen of several hemopoietic cell lineages, inducible on monocytes by IFN-gamma.
Posnett DN; Duggan A; McGrath H
J Immunol; 1990 Feb; 144(3):929-33. PubMed ID: 2104914
[TBL] [Abstract][Full Text] [Related]
5. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
[TBL] [Abstract][Full Text] [Related]
6. A B cell-restricted activation antigen (B8.7) functionally related to the low molecular weight B cell growth factor receptor.
Leprince C; Richard Y; Krief P; Treton D; Boucheix C; Galanaud P
J Immunol; 1988 Jan; 140(1):100-7. PubMed ID: 3257225
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
[TBL] [Abstract][Full Text] [Related]
8. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
Sherris D; Stohl W; Mayer L
J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
[TBL] [Abstract][Full Text] [Related]
9. Expression of B cell activation antigens on normal and malignant B cells.
Freedman AS; Boyd AW; Berrebi A; Horowitz JC; Levy DN; Rosen KJ; Daley J; Slaughenhoupt B; Levine H; Nadler LM
Leukemia; 1987 Jan; 1(1):9-15. PubMed ID: 3118102
[TBL] [Abstract][Full Text] [Related]
10. Activation of human B lymphocytes through CD40 and interleukin 4.
Vallé A; Zuber CE; Defrance T; Djossou O; De Rie M; Banchereau J
Eur J Immunol; 1989 Aug; 19(8):1463-7. PubMed ID: 2476318
[TBL] [Abstract][Full Text] [Related]
11. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
[TBL] [Abstract][Full Text] [Related]
12. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.
Thorley-Lawson DA; Nadler LM; Bhan AK; Schooley RT
J Immunol; 1985 May; 134(5):3007-12. PubMed ID: 2984280
[TBL] [Abstract][Full Text] [Related]
13. B7, a B-cell-restricted antigen that identifies preactivated B cells.
Freedman AS; Freeman G; Horowitz JC; Daley J; Nadler LM
J Immunol; 1987 Nov; 139(10):3260-7. PubMed ID: 3500211
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel human B cell activation antigen involved in B cell growth factor-dependent proliferation.
Tseng CT; Springgate CF; Tadmori W; Choi YS
J Immunol; 1988 Apr; 140(7):2305-11. PubMed ID: 2450917
[TBL] [Abstract][Full Text] [Related]
15. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
[TBL] [Abstract][Full Text] [Related]
16. Surface marker expression of human B-cell lymphomas.
Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
[TBL] [Abstract][Full Text] [Related]
17. A new antigen identified by the monoclonal antibody UCHB 1 delivers a costimulatory signal to a subset of human B cells.
Armitage RJ; Rowe DJ; Beverly PC
Eur J Immunol; 1988 Jan; 18(1):67-76. PubMed ID: 3257923
[TBL] [Abstract][Full Text] [Related]
18. Activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
Salter DM; Krajewski AS; Cunningham S
J Pathol; 1988 Mar; 154(3):209-22. PubMed ID: 3280770
[TBL] [Abstract][Full Text] [Related]
19. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
20. Identification of an early activation antigen (Bac-1) on human B cells.
Suzuki T; Sanders SK; Butler JL; Gartland GL; Komiyama K; Cooper MD
J Immunol; 1986 Aug; 137(4):1208-13. PubMed ID: 3090143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
